Skip to content

Clinics will need new systems to administer injectable HIV therapies, says Canadian early adopter

Dr Jonathan Angel presenting to EACS 2021.

Potent new anti-HIV drug only needs to be injected once every six months

Peter Stanic/Pixabay

Long-acting injectable HIV treatment is feasible, even during COVID-19

Slide from Dr Maggie Czarnogorski's presentation to IAS 2021.

Twice-a-year injected drug shows promise for first-line HIV treatment

Professor Samir Gupta

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy

Peter Stanic/Pixabay

Injectable HIV therapy should only be given after a check for innate resistance, French study suggests

Karan Bunjean/Shutterstock.com

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

funnyangel/Shutterstock.com

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

Professor Raphael Landovitz presenting findings on injectable PrEP to CROI 2021.

Injectable HIV medications must be practical and affordable, conference hears

Carlos del Rio, Diane Havlir, Charles Flexner, Francois Venter, Hyman Scott, Nittaya Phanuphak (top to bottom, left to right) at CROI 2021.